Kaimin Guo

Mr. Kaimin Guo

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
YWYu Wei
Yu Wei
RZRuili Zhang
Ruili Zhang
XLXiaoqiang Li
Xiaoqiang Li
ZLZhonglin Li
Zhonglin Li
KGKaimin Guo
Kaimin Guo
YHYUNHUI HU
YUNHUI HU
Diabetic retinopathy (DR), a diabetic microangiopathy caused by diabetes, affects approximately 93 million people, worldwide. However, the drugs used to treat DR have limited efficacy and the variety of side effects. This is possibly because the complicated pathogenesis of DR is associated with multiple proteins. In this work, we attempted to identify potential drugs against DR‐associated proteins and predict potential targets for drugs using in silico prediction of chemical‐protein interactions (CPI) based on multitarget quantitative structure‐activity relationship (mt‐QSAR) method. Therefore, we developed 128 binary classifiers to predict the CPI for 15 DR targets using random forest (RF), k‐nearest neighbours (KNN), support vector machine (SVM), and neural network (NN) algorithms with MACCS, extended connectivity fingerprints (ECFP6) fingerprints, and protein descriptors. In order to facilitate discovery of the novel drugs and target identification using the 128 binary classifiers, a free web server (DRDB) was developed. Compound Danshen Dripping Pills (CDDP), composed of Salvia miltiorrhiza, Panax notoginseng, and borneol, is commonly used in the treatment of cardiovascular diseases. To explore the applicability of DRDB, the potential CPIs of CDDP in treatment of DR were investigated based on DRDB. In vitro experimental validation demonstrated that cryptotanshinone and protocatechuic acid, two key components of CDDP, are capable of targeting ICAM‐1 which is one of the key target of DR. We hope that this work can facilitate development of more effective clinical strategies for the treatment of DR.

6 August 2013 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
NXNing Xu
Ning Xu
FLFubiao Li
Fubiao Li
RTRunhui Tian
Runhui Tian
MSMingming Shao
Mingming Shao
LLLingyun Liu
Lingyun Liu
KGKaimin Guo
Kaimin Guo
Spermatocytic seminoma (SS) is a rare testicular neoplasm characterized by a palpable, painless, slowly enlarging mass in the testis. Even more rare is a synchronous bilateral presentation. Only eight cases of bilateral SS have been reported in the literature, of which three cases were present with synchronous testis enlargement, and five were sequential. Here, we report an additional case of synchronous bilateral SS and present a comprehensive relevant literature review concerning clinical features, histopathology, and treatment.

28 September 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
KGKaimin Guo
Kaimin Guo
YJYang Jinna
Yang Jinna
JJJiang Jiang
Jiang Jiang
XRXiaxia Ren
Xiaxia Ren
PLPeng Liu
Peng Liu
YHYUNHUI HU
YUNHUI HU
Background: Gliomas, the most prevalent type of primary brain tumor, stand out as one of the most aggressive and lethal types of human cancer. Methods & Results: To uncover potential prognostic markers, we employed the weighted correlation network analysis (WGCNA) on the Chinese Glioma Genome Atlas (CGGA) 693 dataset to reveal four modules significantly associated with glioma clinical traits, primarily involved in immune function, cell cycle regulation, and ribosome biogenesis. Using the least absolute shrinkage and selection operator (LASSO) regression algorithm, we identified 11 key genes and developed a prognostic risk score model, which exhibits precise prognostic prediction in the CGGA 325 dataset. More importantly, we also validated the model in 12 glioma patients with overall survival (OS) ranging from 4 to 132 months using mRNA sequencing and immunohistochemical analysis. The analysis of immune infiltration revealed that patients with high-risk scores exhibit a heightened immune infiltration, particularly immune suppression cells, along with increased expression of immune checkpoints. Furthermore, we explored potentially effective drugs targeting 11 key genes for gliomas using the library of integrated network-based cellular signatures (LINCS) L1000 database, identifying that in vitro, both torin-1 and clofarabine exhibit promising anti-glioma activity and inhibitory effect on the cell cycle, a significant pathway enriched in the identified glioma modules. Conclusions: In conclusion, our study provides valuable insights into molecular mechanisms and identifying potential therapeutic targets for gliomas.

1 November 2017 in The American Journal of Pathology
Verified
Journal Article
Closed access
EMErin M. McAuley
Erin M. McAuley
DMDevkumar Mustafi
Devkumar Mustafi
BSBrian W. Simons
Brian W. Simons
RVRebecca Valek
Rebecca Valek
MZMarta Zamora
Marta Zamora
YZYifang Zhao
Yifang Zhao